Related Experiment Video
Updated: Jun 19, 2026
11:44
Isolation of Stem Cells from Human Pancreatic Cancer Xenografts
Published on: September 26, 2010
[Role of prostate stem cell antigen in human pancreatic carcinoma: a tissue microarray-based study]
Wen-bin Yang1, Feng Cai, Chuan-tao Cheng
1Department of General Surgery, Second Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an 710004, China. yangwb66@yahoo.com.cn
Summary
Prostate stem cell antigen (PSCA) is highly expressed in pancreatic cancer, suggesting a role in oncogenesis. However, PSCA levels did not correlate with tumor stage or other clinical factors in this study.
Area of Science:
- Oncology
- Molecular Biology
Context:
- Pancreatic cancer is a deadly disease with limited therapeutic options.
- Understanding the molecular mechanisms driving pancreatic cancer is crucial for developing new treatments.
Purpose:
- To investigate the expression of prostate stem cell antigen (PSCA) in human pancreatic carcinoma.
- To explore the role of PSCA in pancreatic cancer oncogenesis.
Summary:
- PSCA was detected in 79.5% of pancreatic carcinomas, with significantly higher intensity in malignant cells compared to normal or chronic pancreatitis tissues.
- PSCA expression did not show a correlation with clinicopathological factors such as gender, age, tumor grade, or TNM stage.
Impact:
- This study indicates that PSCA may be involved in the development of pancreatic cancer.
- Further research is needed to elucidate the precise role of PSCA in pancreatic cancer progression and its potential as a therapeutic target.
